A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to compare two capsules of topotecan made by slightly different methods. This will be done by giving the drug made by the two different methods to patients orally and testing blood levels.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00046111
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 1
Start date	September 2001
Completion date	April 2004

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT06293833` - Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan	N/A
	Completed	`NCT00259935` - A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors	Phase 1
	Completed	`NCT01037023` - Regulatory Hycamtin(Oral) PMS	N/A
	Active, not recruiting	`NCT04986670` - NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer	N/A
	Completed	`NCT00997061` - SCOT Registry: Small Cell Lung Cancer Treatment and Outcome	N/A
	Completed	`NCT00276276` - Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer	Phase 3
	Not yet recruiting	`NCT05320458` - Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer	N/A
	Active, not recruiting	`NCT05228496` - A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC	Phase 2
	Completed	`NCT00316186` - First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin	Phase 2
	Not yet recruiting	`NCT04440800` - Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment
	Completed	`NCT00698516` - Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer	Phase 2
	Terminated	`NCT03499678` - Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
	Terminated	`NCT01313663` - A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population	Phase 2
	Active, not recruiting	`NCT04660929` - CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors	Phase 1
	Completed	`NCT00043862` - The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)	Phase 2
	Completed	`NCT00320359` - Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer	Phase 3
	Recruiting	`NCT06228326` - A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs	Phase 1
	Completed	`NCT04314895` - Trial of NanoPac Intratumoral Injection in Lung Cancer	Phase 2